http://www.unboundmedicine.com/medline/ebm/research/bicalutamideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19886863/full_citation/Androgen_regulation_of_the_prostatic_tumour_suppressor_NKX3_1_is_mediated_by_its_3'untranslated_region_Thomas MA, Preece DM, Bentel JM 
Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3'untranslated region. [JOURNAL ARTICLE]
Biochem J 2009 Nov 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19836827/full_citation/Consolidation_strategies_in_ovarian_cancer:_Observations_for_future_clinical_trials_Sabbatini P, Spriggs D, Aghajanian C, et al. 
Consolidation strategies in ovarian cancer: Observations for future clinical trials. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Oct 15.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19798757/full_citation/Physicochemical_characterization_of_hot_melt_extruded_bicalutamide_polyvinylpyrrolidone_solid_dispersions_Andrews GP, Abudiak OA, Jones DS 
Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. [JOURNAL ARTICLE]
J Pharm Sci 2009 Oct 1.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19796455/full_citation/Dutasteride_and_bicalutamide_in_patients_with_hormone_refractory_prostate_cancer:_The_Therapy_Assessed_by_Rising_PSA__TARP__study_rationale_and_design_Sartor O, Gomella LG, Gagnier P, et al. 
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: The Therapy Assessed by Rising PSA (TARP) study rationale and design. [Journal Article]
Can J Urol 2009 Oct; 16(5):4806-12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19790238/full_citation/Antiandrogen_withdrawal_syndrome_and_alternative_antiandrogen_therapy_associated_with_the_W741C_mutant_androgen_receptor_in_a_novel_prostate_cancer_xenograft_Terada N, Shimizu Y, Yoshida T, et al. 
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft. [JOURNAL ARTICLE]
Prostate 2009 Sep 29.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19790234/full_citation/Induction_of_bicalutamide_sensitivity_in_prostate_cancer_cells_by_an_epigenetic_Puralpha_mediated_decrease_in_androgen_receptor_levels_Liu X, Gomez-Pinillos A, Liu X, et al. 
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels. [JOURNAL ARTICLE]
Prostate 2009 Sep 29.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19787268/full_citation/Epigenetic_modulation_of_PTEN_expression_during_antiandrogenic_therapies_in_human_prostate_cancer_Gravina GL, Biordi L, Martella F, et al. 
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer. [Journal Article]
Int J Oncol 2009 Nov; 35(5):1133-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19733987/full_citation/Beyond_castration_and_chemotherapy:_Novel_approaches_to_targeting_androgen_driven_pathways_Pal SK, Twardowski P, Josephson DY 
Beyond castration and chemotherapy: Novel approaches to targeting androgen-driven pathways. [JOURNAL ARTICLE]
Maturitas 2009 Sep 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19683286/full_citation/Pathological_effects_of_prostate_cancer_correlate_with_neuroendocrine_differentiation_and_PTEN_expression_after_bicalutamide_monotherapy_Ham WS, Cho NH, Kim WT, et al. 
Pathological effects of prostate cancer correlate with neuroendocrine differentiation and PTEN expression after bicalutamide monotherapy. [Journal Article, Research Support, Non-U.S. Gov't]
J Urol 2009 Oct; 182(4):1378-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19654297/full_citation/Discovery_of_BMS_641988_a_novel_and_potent_inhibitor_of_androgen_receptor_signaling_for_the_treatment_of_prostate_cancer_Attar RM, Jure-Kunkel M, Balog A, et al. 
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer. [Journal Article]
Cancer Res 2009 Aug 15; 69(16):6522-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles